These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8934120)

  • 41. [Morphological imaging for response assessment in metastatic bone disease].
    Feydy A
    Bull Cancer; 2013 Nov; 100(11):1125-34. PubMed ID: 24197057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging of metastases to the liver.
    Mahfouz AE; Hamm B; Mathieu D
    Eur Radiol; 1996; 6(5):607-14. PubMed ID: 8934122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic imaging and image-guided therapy of skeletal metastases.
    Choi J; Raghavan M
    Cancer Control; 2012 Apr; 19(2):102-12. PubMed ID: 22487972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and radiologic characteristics of bone metastases in breast cancer.
    Kamby C; Vejborg I; Daugaard S; Guldhammer B; Dirksen H; Rossing N; Mouridsen HT
    Cancer; 1987 Nov; 60(10):2524-31. PubMed ID: 3664434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
    Brown B; Laorr A; Greenspan A; Stadalnik R
    Clin Nucl Med; 1994 Mar; 19(3):194-6. PubMed ID: 8033466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.
    Tryciecky EW; Gottschalk A; Ludema K
    Semin Nucl Med; 1997 Apr; 27(2):142-51. PubMed ID: 9144856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
    Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
    Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metastatic disease of the skeleton.
    Buckwalter JA; Brandser EA
    Am Fam Physician; 1997 Apr; 55(5):1761-8. PubMed ID: 9105203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Choice of the imaging technique for the diagnosis of bone metastases].
    Genovese EA; Mallardo V; Rosati I; Prisco MR; Fontanarosa A; Della Vecchia N; D'Agosto G; Santagata M; Basile A
    Recenti Prog Med; 2013; 104(7-8):361-6. PubMed ID: 24042408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of bone metastasis: recent comparative studies of imaging modalities.
    Talbot JN; Paycha F; Balogova S
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):374-410. PubMed ID: 21738113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.
    Haubold-Reuter BG; Duewell S; Schilcher BR; Marincek B; von Schulthess GK
    Eur J Nucl Med; 1993 Nov; 20(11):1063-9. PubMed ID: 8287874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skeletal metastases.
    Thrall JH; Ellis BI
    Radiol Clin North Am; 1987 Nov; 25(6):1155-70. PubMed ID: 3671711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
    Perrin-Resche I; Bizais Y; Buhe T; Fiche M
    Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Total body MRI in early detection of bone metastasis and its indication in comparison to bone scan and other imaging techniques].
    Luna A; Vilanova JC; Alcalá Mata L
    Arch Esp Urol; 2015 Apr; 68(3):371-90. PubMed ID: 25948807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.